drugset / Trial / NCT00943566
A Safety and Efficacy Study of Sufentanil Transdermal System in Patients With Chronic Pain Due to Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
The study hypothesis is that the safety and efficacy of sufentanil following transdermal application is comparable to sustained release morphine sulphate tablets in patients with chronic pain due to cancer.
Timeline
- Start
- 2010-01
- Primary completion
- 2010-12
- Completion
- 2011-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Morphine | Other / unclassified | 400 mg | — |
| Subject | Sufentanil | Other / unclassified | — | Other |